Ravelcare first-half profit rises 20% to Rs 3.84 crore as income rises
Key highlights
- Ravelcare reported net profit of Rs 3.8367 crore for the half year ended September 30, 2026, up 19.8% year on year.
- Revenue from operations increased 5.2% to Rs 15.1515 crore from Rs 14.3976 crore.
- Profit before tax rose 19.2% to Rs 5.1736 crore while total expenses increased 5.9% to Rs 10.7002 crore.
- Other income increased to Rs 72.23 lakh from Rs 16.10 lakh, lifting total income 8.5% to Rs 15.6737 crore.
powered by IRIS

Ravelcare Limited reported unaudited standalone net profit of Rs 3.8367 crore for the half year ended September 30, 2026, up 19.8% from Rs 3.2027 crore a year earlier, as revenue from operations rose 5.2% to Rs 15.1515 crore and profit before tax reached Rs 5.1736 crore.
Know Ravelcare inside out
Results, valuation, peers and who's buying, in one view.
How did Ravelcare's first-half profit change?
Ravelcare's net profit increased by Rs 63.40 lakh from the half year ended September 30, 2025. Net profit was Rs 3.8367 crore in the September 2026 half year, compared with Rs 3.2027 crore in the corresponding prior-year period. The statement shows no profit or loss from discontinued operations in either reported half year.
The September 2026 result was also higher than the Rs 1.9515 crore net profit reported for the half year ended March 31, 2026. That comparison represents an increase of Rs 1.8852 crore. Ravelcare and its auditor note that the March 2026 half-year figures are balancing figures between the audited financial year ended March 31, 2026 and the audited half year ended September 30, 2025.
What lifted Ravelcare's total income?
Ravelcare's total income increased by Rs 1.2299 crore to Rs 15.6737 crore in the half year ended September 30, 2026. Revenue from operations increased by Rs 75.39 lakh to Rs 15.1515 crore, while other income rose to Rs 72.23 lakh from Rs 16.10 lakh. Total-income growth of 8.5% therefore exceeded the 5.2% rise in operating revenue.
Other income accounted for Rs 72.23 lakh of the September 2026 total, compared with Rs 16.10 lakh a year earlier. Based on the reported values, it represented about 4.6% of total income, against about 1.1% in the prior-year half year. The financial statement does not give a breakdown of the other-income line or identify the source of its increase.
Revenue from operations also rose from Rs 12.5567 crore in the half year ended March 31, 2026 to Rs 15.1515 crore in the September 2026 half year. Total income increased from Rs 12.5954 crore over the same sequential comparison. The September result therefore included both higher operating revenue and a larger disclosed other-income contribution than the immediately preceding half year.
Which costs changed in Ravelcare's half-year results?
Ravelcare's total expenses rose by Rs 59.72 lakh to Rs 10.7002 crore in the half year ended September 30, 2026, from Rs 10.1030 crore a year earlier. The 5.9% increase in expenses was below the 8.5% growth in total income. As a result, profit before tax increased by Rs 83.28 lakh to Rs 5.1736 crore.
Other expenses were the largest displayed cost line at Rs 6.9196 crore, compared with Rs 6.0329 crore in the half year ended September 30, 2025. Purchases of stock-in-trade increased to Rs 2.9065 crore from Rs 2.3090 crore, while employee benefit expense rose to Rs 71.23 lakh from Rs 53.73 lakh. Depreciation and amortisation expense declined to Rs 28.90 lakh from Rs 35.40 lakh.
Changes in inventories of finished goods, work-in-progress and stock-in-trade were Rs 13.28 lakh, compared with Rs 91.47 lakh in the corresponding prior-year period. Ravelcare reported no finance costs, provisions and loan losses, or exceptional items in the displayed statement for the September 2026 half year. These lines therefore did not add to the reported movement between operating costs and profit before tax.
Got a follow-up? Ask IRIS
How did tax and per-share earnings move at Ravelcare?
Ravelcare reported current tax of Rs 1.3032 crore for the September 2026 half year, compared with Rs 1.0999 crore a year earlier. Deferred tax was Rs 3.36 lakh, down from Rs 5.52 lakh. Profit before tax increased to Rs 5.1736 crore from Rs 4.3408 crore, while net profit increased to Rs 3.8367 crore from Rs 3.2027 crore.
Basic and diluted earnings per share, or EPS, were Rs 5.59 for the half year ended September 30, 2026, compared with Rs 6.40 for the half year ended September 30, 2025. The filing reports paid-up equity share capital of Rs 6.859 crore at September 30, 2026, versus Rs 5.005 crore a year earlier. It does not state the reason for the EPS change, but says half-year EPS is based on weighted average outstanding share capital and is not annualised.
Net profit represented about 24.5% of total income in the September 2026 half year, calculated from the disclosed Rs 3.8367 crore profit and Rs 15.6737 crore total income. The equivalent calculation was about 22.2% in the September 2025 half year, using Rs 3.2027 crore of net profit and Rs 14.4438 crore of total income. Ravelcare did not disclose a margin target or profit forecast in the announcement.
What is the reporting scope and review status?
Ravelcare's figures cover the six months from April 1, 2026 to September 30, 2026 and are standalone and unaudited. The Audit Committee and Board of Directors reviewed and approved the results on November 13, 2026. The company informed BSE Limited of the board-meeting outcome on the same date.
Ratan Chandak & Co LLP performed a limited review under Regulation 33 of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements Regulations, 2015. The auditor said nothing had come to its attention to suggest the statement failed to disclose required information or contained a material misstatement. It also said a review provides moderate assurance and is not an audit.
Ravelcare reported that it operates in one segment, so segment reporting under Accounting Standard 17 does not apply. The filing states that certain companies listed on the small and medium enterprises exchange are exempt from compulsory adoption of Indian Accounting Standards under the cited Ministry of Corporate Affairs notification. Ravelcare also reported no pending investor complaints as of September 30, 2026.
Conclusion
Ravelcare combined 5.2% growth in revenue from operations with a 19.8% increase in net profit for the half year ended September 30, 2026. Total income rose 8.5% to Rs 15.6737 crore, supported by Rs 72.23 lakh of other income, while total expenses rose 5.9% to Rs 10.7002 crore and profit before tax reached Rs 5.1736 crore.
The next result will show whether operating revenue can build on the Rs 15.1515 crore reported for the September 2026 half year and whether other income remains elevated. The announcement leaves the source of the Rs 72.23 lakh other-income line unresolved and discloses no revenue target, profit target, operating plan or scheduled future corporate event.


